Cannabis News and Research

Latest Cannabis News and Research

Cannabis Science seeks entry into European medical cannabis market

Cannabis Science Inc., a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that the Company is currently raising working capital in the European market and pursuing listings on the Frankfurt and other major European exchanges.

30 Aug 2010

Smoked cannabis relieves chronic neuropathic pain

The medicinal use of cannabis has been debated by clinicians, researchers, legislators and the public at large for many years as an alternative to standard pharmaceutical treatments for pain, which may not always be effective and may have unwanted side effects. A new study by McGill University Health Centre (MUHC) and McGill University researchers provides evidence that cannabis may offer relief to patients suffering from chronic neuropathic pain.

30 Aug 2010

CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids

The Government of Ontario's narcotics strategy will address the root causes of a significant and growing health problem - the inappropriate use of prescription opioids. The Centre for Addiction and Mental Health (CAMH) welcomes the strategy announced by The Honourable Deb Matthews, Minister of Health and Long-Term Care.

30 Aug 2010

23rd ECNP Congress press conference

The incidence of psychotic disorders varies greatly across places and demographic groups, as do symptoms, course, and treatment response across individuals. High rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in combination with progress in the area of molecular genetics, has generated interest in more complicated models of schizophrenia aetiology that explicitly posit gene-environment interactions.

30 Aug 2010

Researchers find smoked cannabis reduces chronic neuropathic pain

For people suffering chronic pain, smoked cannabis reduces pain, improves mood and helps sleep, according to new research published in CMAJ.

30 Aug 2010

Continuous boosting of natural painkiller shuts down brain cell receptor response

ERepeatedly boosting brain levels of one natural painkiller soon shuts down the brain cell receptors that respond to it, so that the painkilling effect is lost, according to a surprising new study led by Scripps Research Institute and Virginia Commonwealth University scientists. The study has important implications for drug development.

25 Aug 2010

Fla.'s Jackson Health System struggles with nursing home and hospital losses; Advocates push marijuana cultivation in Calif.

The Miami Herald: As the Jackson Health System's "governing board prepares to vote Monday on a proposed budget for 2011, its two money-losing nursing homes stand as a symbol for the challenges the system faces as it attempts to cut losses. Almost 100 of the 289 nursing home patients in the Jackson Health System are uninsured. Half of those are undocumented immigrants under age 50.

24 Aug 2010

Montana Pain Management in breach of non-disclosure/non-circumvention agreement with Cannabis Science

Cannabis Science Inc., a pioneering US biotech company developing pharmaceutical cannabis products, reports that Cannabis Science sent an email to Mr. Rick Rosio on July 23, 2010 notifying him that he appeared to be in serious breach of the non-disclosure/non-circumvention agreement that he and Montana Pain Management, Inc., had signed with Cannabis Science.

19 Aug 2010

Effects of illegal drugs on health

Illegal drugs are responsible for up to 1,600 deaths a year in the UK, and destroy thousands of relationships, families and careers. Find out about the most commonly used illegal drugs in England and Wales and the effects they can have on your health.

19 Aug 2010

Cannabis Science signs manufacturing and development license with RockBrook

Cannabis Science Inc. a pioneering US biotech company developing pharmaceutical cannabis products, announces that on August 18, 2010, Cannabis Science signed with RockBrook Inc., its first manufacturing and development license for the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado.

19 Aug 2010

‘Decriminalize’ but not ‘Legalize’ drug abuse says Australian Sex party

Professor Paul Wilson, an Australian criminologist revealed that illegal drug use in Australia costs the nation $3.8 billion every year. Australian Sex Party however claims personal drug use should be decriminalized and drug abusers sent for rehabilitation instead of imprisonment.

10 Aug 2010

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

A newly discovered molecular mechanism helps control the amount and effectiveness of a substance that mimics an active ingredient in marijuana, but that is produced by the body's own nerve cells.

7 Aug 2010

Cannabis Medical Solutions signs merchant services agreements with four medical marijuana dispensaries

Cannabis Medical Solutions Inc., a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts, today announced that the Company has signed merchant services agreements with four additional medical marijuana dispensaries located in California and Colorado. Under the new agreements, CMSI will provide merchant services, cash advance POS systems and The MediPayment closed loop patient system to the licensed dispensaries.

2 Aug 2010

Study examines effects of binge drinking on prospective memory in teenagers

Academics at Northumbria University have demonstrated a link between teenage binge drinking and damage to prospective memory. Prospective memory is an important aspect of day-to-day memory function and is defined as the cognitive ability to remember to carry out an activity at some future point in time. Examples include remembering to attend an appointment at the dentist or to carry out a task such as remembering to pay a bill on time.

29 Jul 2010

Cash-strapped local governments threaten to hold back payments to N.Y.; Oakland council approves 4 marijuana factories

The Wall Street Journal: "Frustrated by Albany's backlog of unpaid bills, cash-strapped local governments around New York are threatening to suspend their Medicaid payments to the state. Last week, an upstate county announced that it was freezing Medicaid payments to Albany. The move, which was closely watched by other county leaders, may be the start of a broader revolt, as the consequences of the state's chronic cash shortage trickle down to the local level.

27 Jul 2010

1 yr old tested positive for angel dust and cocaine

In a shocking incident, a one year old boy baby tested positive for the drug Phencyclidine (PCP) commonly known as “angel dust” and cocaine after his parents took him to a hospital in Chicago.

26 Jul 2010

CMSI signs Letter of Intent with Green Medicals to acquire equity interest in 8 medical marijuana dispensaries

Cannabis Medical Solutions Inc., a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts, today announced that the Company has signed a Letter of Intent with Green Medicals LLC to acquire equity interest in up to eight (8) medical marijuana dispensaries within the state of Colorado.

26 Jul 2010

Largest effort to find gene-environment interactions underlying schizophrenia risk

At the 23rd ECNP Congress 2010 in Amsterdam, Professor Dr. Jim van Os, Chairman of the Department of Psychiatry and Neuropsychology at Maastricht University Medical Centre, The Netherlands, will present the EU-GEI project, involving more than 7,500 patients and their families, which brings together a multidisciplinary research team from 15 countries in the largest effort to date to find gene-environment interactions underlying schizophrenia risk.

16 Jul 2010

Cannabis Science enters into long-term lease on 9,500 square foot facility in Denver, Colorado

Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce that it has entered into a long-term lease on a 9,500 square foot facility in Denver, Colorado, that will become its corporate offices, as well as serving as a research facility for developing, testing, and producing medical cannabis for patients in compliance with the new Colorado laws regulating medical marijuana in the state.

8 Jul 2010

Marijuana legalization in California will lower drug price and increase consumption

Legalizing the production and distribution of marijuana in California could cut the price of the drug by as much as 80 percent and increase consumption, according to a new study by the nonprofit RAND Corporation that examines many issues raised by proposals to legalize marijuana in the state.

8 Jul 2010

Cannabis News and Research

Latest Cannabis News and Research

Cannabis Science seeks entry into European medical cannabis market

Smoked cannabis relieves chronic neuropathic pain

CAMH welcomes Ontario's narcotics strategy to address inappropriate use of prescription opioids

23rd ECNP Congress press conference

Researchers find smoked cannabis reduces chronic neuropathic pain

Continuous boosting of natural painkiller shuts down brain cell receptor response

Fla.'s Jackson Health System struggles with nursing home and hospital losses; Advocates push marijuana cultivation in Calif.

Montana Pain Management in breach of non-disclosure/non-circumvention agreement with Cannabis Science

Effects of illegal drugs on health

Cannabis Science signs manufacturing and development license with RockBrook

‘Decriminalize’ but not ‘Legalize’ drug abuse says Australian Sex party

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study

Cannabis Medical Solutions signs merchant services agreements with four medical marijuana dispensaries

Study examines effects of binge drinking on prospective memory in teenagers

Cash-strapped local governments threaten to hold back payments to N.Y.; Oakland council approves 4 marijuana factories

1 yr old tested positive for angel dust and cocaine

CMSI signs Letter of Intent with Green Medicals to acquire equity interest in 8 medical marijuana dispensaries

Largest effort to find gene-environment interactions underlying schizophrenia risk

Cannabis Science enters into long-term lease on 9,500 square foot facility in Denver, Colorado

Marijuana legalization in California will lower drug price and increase consumption

Cannabis Testing & Analysis eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech